Current Strategies in the Development of Nanoformulations to Enhance the Stability of Botox: A Systematic Review.
TL;DR
Nanoformulations with metallic/polymeric nanoparticles and hydrogels greatly increase Botox's stability and its duration of action and in the future, physicochemical properties and safety profiles of these formulations should be optimized for clinical application.
OpenAlex 토픽 ·
Advanced Drug Delivery Systems
Heme Oxygenase-1 and Carbon Monoxide
Drug Solubulity and Delivery Systems
Nanoformulations with metallic/polymeric nanoparticles and hydrogels greatly increase Botox's stability and its duration of action and in the future, physicochemical properties and safety profiles of
APA
Nazanin Ajdary, Mehdi Shafiee Ardestani, et al. (2025). Current Strategies in the Development of Nanoformulations to Enhance the Stability of Botox: A Systematic Review.. AAPS PharmSciTech, 27(1), 38. https://doi.org/10.1208/s12249-025-03225-1
MLA
Nazanin Ajdary, et al.. "Current Strategies in the Development of Nanoformulations to Enhance the Stability of Botox: A Systematic Review.." AAPS PharmSciTech, vol. 27, no. 1, 2025, pp. 38.
PMID
41254401
Abstract
[PURPOSE] The therapeutic application of Botox is limited due to its inherent structural instability, rapid degradation, and the need for frequent and painful injections. Since nanotechnology-based formulations could provide a solution to these problems, this study systematically investigated the development of stable nanoformulated Botox.
[METHODS] Following PRISMA 2020 guidelines, a systematic search was carried out across PubMed, Web of Science, Scopus, and Google Scholar using both MeSH and non-MeSH keywords, with no date restrictions. Original English-language studies and patents evaluating nanotechnology methods to improve Botox stability in human, animal, or cell models were included. Various nanoformulation approaches, such as high-pressure microfluidization, emulsion and polymer template microfabrication, flash nano-complexation, polyelectrolyte complexation, electrochemical methods, autologous fat emulsification, and reverse-thermal gelation, were examined. Data on synthesis, particle characteristics, buffers/excipients, stability, administration routes, dosing, and efficacy were extracted. Risk of bias was evaluated using both SYRCLE's and Cochrane's RoB 2 tools.
[RESULTS] Nano-Botox exhibited superior stability to heat, pH changes, and enzymatic degradation. Different nanosystems (10-300 nm) and polymeric microparticles (< 100 μm), administered intramuscularly, transdermally, or topically, extended the duration of action from one week to more than 11 months. Silver nanoparticle-based diluents extended refrigerated stability of Botox up to 3-4 months and its clinical efficacy up to > 11 months. Polyethylene glycol derivatives of nano-Botox also revealed promising results.
[CONCLUSION] Nanoformulations with metallic/polymeric nanoparticles and hydrogels greatly increase Botox's stability and its duration of action. In the future, physicochemical properties and safety profiles of these formulations should be optimized for clinical application.
[METHODS] Following PRISMA 2020 guidelines, a systematic search was carried out across PubMed, Web of Science, Scopus, and Google Scholar using both MeSH and non-MeSH keywords, with no date restrictions. Original English-language studies and patents evaluating nanotechnology methods to improve Botox stability in human, animal, or cell models were included. Various nanoformulation approaches, such as high-pressure microfluidization, emulsion and polymer template microfabrication, flash nano-complexation, polyelectrolyte complexation, electrochemical methods, autologous fat emulsification, and reverse-thermal gelation, were examined. Data on synthesis, particle characteristics, buffers/excipients, stability, administration routes, dosing, and efficacy were extracted. Risk of bias was evaluated using both SYRCLE's and Cochrane's RoB 2 tools.
[RESULTS] Nano-Botox exhibited superior stability to heat, pH changes, and enzymatic degradation. Different nanosystems (10-300 nm) and polymeric microparticles (< 100 μm), administered intramuscularly, transdermally, or topically, extended the duration of action from one week to more than 11 months. Silver nanoparticle-based diluents extended refrigerated stability of Botox up to 3-4 months and its clinical efficacy up to > 11 months. Polyethylene glycol derivatives of nano-Botox also revealed promising results.
[CONCLUSION] Nanoformulations with metallic/polymeric nanoparticles and hydrogels greatly increase Botox's stability and its duration of action. In the future, physicochemical properties and safety profiles of these formulations should be optimized for clinical application.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botox
|
보툴리눔독소 주사 | dict | 8 | |
| 해부 | cell
|
scispacy | 1 | ||
| 해부 | fat
|
scispacy | 1 | ||
| 약물 | Nanoformulations
|
scispacy | 1 | ||
| 약물 | Silver
|
C0037125
Silver
|
scispacy | 1 | |
| 약물 | Polyethylene glycol
|
C0032483
polyethylene glycols
|
scispacy | 1 | |
| 약물 | polyelectrolyte
|
scispacy | 1 | ||
| 약물 | reverse-thermal
|
scispacy | 1 | ||
| 약물 | Polyethylene glycol derivatives
|
scispacy | 1 | ||
| 기타 | Botox:
|
scispacy | 1 | ||
| 기타 | human
|
scispacy | 1 |
MeSH Terms
Drug Stability; Botulinum Toxins, Type A; Humans; Animals; Drug Compounding; Nanoparticles; Chemistry, Pharmaceutical; Particle Size
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.